Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Gotti

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Biochemical Pharmacology|February 18, 2019
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neuronsCarlo Matera, Federica Bono, Silvia Pelucchi, et al.
The European Journal of Neuroscience|May 24, 2018
Molecular and cellular characterization of nicotinic acetylcholine receptor subtypes in the arcuate nucleus of the mouse hypothalamusCali A Calarco, Zhiying Li, Seth R Taylor, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
5-(2-Pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: synthesis of all the stereoisomers and alpha4beta2 nicotinic affinityMarco Pallavicini, Cristiano Bolchi, Matteo Binda, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 16, 2010
Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcementCecilia Gotti, Stefania Guiducci, Vincenzo Tedesco, et al.
Journal of Medicinal Chemistry|July 31, 2015
Chemistry and Pharmacology of a Series of Unichiral Analogues of 2-(2-Pyrrolidinyl)-1,4-benzodioxane, Prolinol Phenyl Ether, and Prolinol 3-Pyridyl Ether Designed as α4β2-Nicotinic Acetylcholine Receptor AgonistsCristiano Bolchi, Ermanno Valoti, Cecilia Gotti, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 23, 2011
Engineering of α-conotoxin MII-derived peptides with increased selectivity for native α6β2* nicotinic acetylcholine receptorsLuca Pucci, Giovanni Grazioso, Clelia Dallanoce, et al.
Journal of Medicinal Chemistry|December 16, 2020
Modifications at C(5) of 2-(2-Pyrrolidinyl)-Substituted 1,4-Benzodioxane Elicit Potent α4β2 Nicotinic Acetylcholine Receptor Partial Agonism with High Selectivity over the α3β4 SubtypeFrancesco Bavo, Marco Pallavicini, Cecilia Gotti, et al.
Plos One|January 6, 2016
Antagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of DiabetesMara Castelli, Giada Amodeo, Lucia Negri, et al.
Psychopharmacology|May 28, 2014
The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptorsLuisa Ponzoni, Daniela Braida, Luca Pucci, et al.
British Journal of Pharmacology|January 15, 2011
Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonistsAnna Maria Capelli, Laura Castelletti, Yu Hua Chen, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Biochemical Pharmacology|February 18, 2019
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neuronsCarlo Matera, Federica Bono, Silvia Pelucchi, et al.
The European Journal of Neuroscience|May 24, 2018
Molecular and cellular characterization of nicotinic acetylcholine receptor subtypes in the arcuate nucleus of the mouse hypothalamusCali A Calarco, Zhiying Li, Seth R Taylor, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
5-(2-Pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: synthesis of all the stereoisomers and alpha4beta2 nicotinic affinityMarco Pallavicini, Cristiano Bolchi, Matteo Binda, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 16, 2010
Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcementCecilia Gotti, Stefania Guiducci, Vincenzo Tedesco, et al.
Journal of Medicinal Chemistry|July 31, 2015
Chemistry and Pharmacology of a Series of Unichiral Analogues of 2-(2-Pyrrolidinyl)-1,4-benzodioxane, Prolinol Phenyl Ether, and Prolinol 3-Pyridyl Ether Designed as α4β2-Nicotinic Acetylcholine Receptor AgonistsCristiano Bolchi, Ermanno Valoti, Cecilia Gotti, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 23, 2011
Engineering of α-conotoxin MII-derived peptides with increased selectivity for native α6β2* nicotinic acetylcholine receptorsLuca Pucci, Giovanni Grazioso, Clelia Dallanoce, et al.
Journal of Medicinal Chemistry|December 16, 2020
Modifications at C(5) of 2-(2-Pyrrolidinyl)-Substituted 1,4-Benzodioxane Elicit Potent α4β2 Nicotinic Acetylcholine Receptor Partial Agonism with High Selectivity over the α3β4 SubtypeFrancesco Bavo, Marco Pallavicini, Cecilia Gotti, et al.
Plos One|January 6, 2016
Antagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of DiabetesMara Castelli, Giada Amodeo, Lucia Negri, et al.
Psychopharmacology|May 28, 2014
The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptorsLuisa Ponzoni, Daniela Braida, Luca Pucci, et al.
British Journal of Pharmacology|January 15, 2011
Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonistsAnna Maria Capelli, Laura Castelletti, Yu Hua Chen, et al.
Pageof 12